-transparent.png){kind=logo}
The cytochrome P450 enzymes constitute a family of phase I enzymes that play a prominent role in the metabolism of a great variety of endogenous and xenobiotic compounds. In this study, the kinetics for the inactivation of cytochrome P450 2E1 by benzyl isothiocyanate (BITC) were elucidated. BITC is a naturally occurring compound found in cruciferous vegetables such as broccoli. BITC inhibited the 7-ethoxy-4-(trifluoromethyl)coumarin (7-EFC) O-deethylation activity of purified and reconstituted P450 2E1 in a time- and concentration-dependent manner. The concentration of inactivator needed for half-maximal inactivation (K(I)) was 13 microM, and the maximum rate of inactivation at saturation (k(inact)) was 0.09 min-1. The partition ratio for the inactivation of P450 2E1 by BITC was found to have an approximate value of 27. Inactivation of P450 2E1 by BITC was dependent on the presence of NADPH. Following incubation for 5 min with BITC, a 65% loss in enzymatic activity was observed, while approximately 74% of the spectrally detectable enzyme remained. 7-Ethoxycoumarin (7-EC), a substrate of P450 2E1, protected P450 2E1 from BITC inactivation, reducing the loss in 7-EFC O-deethylation activity from 50 to 18% when a 1:20 molar ratio of BITC:7-EC was used. Inactivation of P450 2E1 by BITC was irreversible, and no activity was regained after extensive washes to remove BITC. Addition of cytochrome b(5) to the reconstituted system did not affect the rate of inactivation. Reductase activity was unaffected by BITC. The results reported here indicate that BITC is a mechanism-based inactivator of cytochrome P450 2E1 and that the inactivation was primarily due to a modification of the apoprotein by BITC.
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
October 1998,
Chemical research in toxicology,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
December 2000,
Chemical research in toxicology,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
August 2001,
Drug metabolism and disposition: the biological fate of chemicals,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
April 1994,
Clinical pharmacology and therapeutics,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
March 1999,
Anesthesiology,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
May 1997,
Chemical research in toxicology,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
July 2004,
The Journal of pharmacology and experimental therapeutics,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
January 1992,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
June 2001,
Biochemistry,
R L Moreno, and
U M Kent, and
K Hodge, and
P F Hollenberg
September 2004,
Biochemistry,
